UBS Downgrades Braskem to Neutral, Lowers Price Target to $3.8
Benzinga Newsdesk 1 year ago
NewsPenny StocksDowngradesPrice TargetSmall CapAnalyst Ratings
UBS analyst Tasso Vasconcellos downgrades Braskem (NYSE: BAK) from Buy to Neutral and lowers the price target from $5.1 to $3.8.
UBS analyst Tasso Vasconcellos downgrades Braskem (NYSE: BAK) from Buy to Neutral and lowers the price target from $5.1 to $3.8.